Biomarkers for Recurrence in Non-Small Cell Lung Cancer

Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer

Recruiting Observational Study
Non-Small Cell Lung Cancer
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Other
Who this trial is looking for

This trial is looking for patients with non-small cell lung cancer who are having surgery to remove their tumors. Participants will provide samples from their airways during the surgery to help researchers study their cancer.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 18 years old
  • I am having surgery to remove my lung cancer
  • I might have had lung cancer surgery or radiation before

You may not be able to join if

  • I have an active infection or pneumonia
  • My surgeon thinks taking airway samples would cause me extra trouble

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The purpose of this study is to find out if fluid rinsed from peoples' airways (bronchial washing samples) during routine surgery to remove (resect) their non-small cell lung cancer (NSCLC) tumors contains enough vesicles to do testing that may help the researchers learn more about their NSCLC.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients ≥ 18 years of age undergoing consideration of surgical resection, including lobar resections, sublobar resections, and pneumonectomies, for primary lung cancer will be eligible. * Patients with previously resected disease and/or previous radiation therapy will be …
Contacts

David Jones, MD

212-639-6428

jonesd2@mskcc.org

CONTACT

Yuan Liu, MD, PhD

646-888-3640

CONTACT